Antisense & RNAi Therapeutics Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

Uncover key drivers, emerging technologies, and competitive movements shaping the antisense & rnai therapeutics market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Antisense & RNAi Therapeutics Market And What Value Is Projected For 2029?

The antisense & RNAi therapeutics market has experienced substantial expansion in recent years. Its value is projected to grow from $1.75 billion in 2024 to $1.93 billion in 2025, at a compound annual growth rate (CAGR) of 10.2%. Factors contributing to this historical growth include an increase in financial backing, progress in technologies, a rise in healthcare spending, the rapid aging of the population, and economic prosperity within developing markets.

The antisense & RNAi therapeutics market size is anticipated to undergo rapid expansion in the coming years. It is projected to grow to $3.11 billion in 2029, achieving a compound annual growth rate (CAGR) of 12.8%. This growth during the forecast period can be attributed to factors such as improved healthcare accessibility, the rising incidence of cancer, and an increased demand for antisense and RNAi therapeutics, partly influenced by COVID-19. Major trends expected in this period include focused efforts on the research and development of RNA therapeutics for orphan diseases, the adoption of nanoparticles, the advancement of new and enhanced antisense and RNAi therapeutics, and collaborations with other companies for product innovation and revenue generation.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp

What Factors Are Boosting The Antisense & RNAi Therapeutics Market?

The increasing occurrence of coronary artery diseases, neurodegenerative disorders, and infectious diseases is anticipated to boost the demand for the antisense & RNAi therapeutics market. Gene suppression approaches, including RNA interference and antisense oligonucleotides, are employed for the treatment of various neurodegenerative conditions by correcting mutant genes. For instance, in January 2024, according to a report from the American Heart Association, a US-based organization, the age-adjusted death rate from cardiovascular diseases climbed to 233.3 per 100,000, representing a 4.0% rise from the previous year. Consequently, the expanding prevalence of several neurodegenerative diseases and infectious diseases is expected to propel the growth of the antisense & RNAi therapeutics market.

What Are The Core Segmentation Criteria In The Antisense & RNAi Therapeutics Market?

The antisense & rnai therapeutics market covered in this report is segmented –

1) By Technology: RNA Interference, Antisense RNA

2) By Route Of Administration: Intravenous Injections, Intra-dermal Injections, Other Delivery Methods

3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications

Subsegments:

1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), Short Hairpin RNA (shRNA), Dicer-substrate siRNA, MicroRNA (miRNA) Based Therapeutics

2) By Antisense RNA: Antisense Oligonucleotides (ASOs), Morpholino Oligomers, Locked Nucleic Acids (LNAs), Gapmer Antisense Oligonucleotides

Which Emerging Trends Are Reshaping The Antisense & RNAi Therapeutics Market Landscape?

Companies operating within the antisense & RNAi therapeutics market are undertaking strategic initiatives, including collaborations and partnerships, to sustain themselves in the increasingly competitive environment. Strategic collaboration is a business strategy where two or more companies work together to achieve a common objective. For instance, in January 2023, Orbit Discovery Limited, a US-based company providing services for peptide discovery, partnered with SanegeneBio Inc., a UK-based company involved in developing novel RNAi-based medicines. This collaboration aimed to identify tissue-specific delivery methods for RNA therapeutics to achieve efficient gene knockdown, with the goal of developing an advanced RNAi therapeutics portfolio. The partnership encompasses hit identification and cell-based internalization studies, granting Sanegene the option to further develop the hits derived from the screening activities by utilizing Orbit’s proprietary technology for rapid peptide lead discovery. Orbit Discovery’s unique peptide display engine facilitates the screening of large peptide libraries, enabling faster discovery times for relevant peptide leads based on affinity and functional screens.

Which Players Are Shaping The Competitive Landscape Of The Antisense & RNAi TherapeuticsXX Market?

Major companies operating in the antisense & RNAi therapeutics market include Biogen Inc., Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Moderna Inc., Sanofi S.A., Dicerna Pharmaceuticals Inc., Arbutus Biopharma Corporation, Acuitas Therapeutics, Adhera Therapeutics Inc., EdiGene Inc., Sirnaomics Inc., Suzhou Ribo Life Science Co. Ltd, Biocon Limited, Quark Pharmaceuticals, GlaxoSmithKline Plc, Shanghai Junshi Biosciences Co. Ltd., AstraZeneca, Benitec Biopharma Limited, Silence Therapeutics, Dynacure, CN Bio Innovations, Sarepta Therapeutics, Mallinckrodt, Regeneron Pharmaceuticals Inc., Alcyone Lifesciences Inc., Bio-Path Holdings Inc, Calando Pharmaceuticals, Enzon Pharmaceuticals Inc, Celnova Pharma, Pfizer Inc., Taiba Pharma, Gen Ilaç ve Saglik Ürünleri A.S., Egypt Otsuka Pharmaceutical

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

What Regional Trends Are Shaping Growth In The Antisense & RNAi Therapeutics Market?

North America was the largest region in the antisense & RNAi therapeutics market in 2024. The regions covered in the antisense & RNAi therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=3389&type=smp

Browse Through More Reports Similar to the Global Antisense & RNAi Therapeutics Market 2025, By The Business Research Company

Anti Hypertensive Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

Pharmaceutical Api Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-api-manufacturing-global-market-report

Microbiome Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/microbiome-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795